Logos Global Management’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.9M Hold
1,000,000
0.72% 42
2025
Q4
$13.8M Buy
1,000,000
+65,000
+7% +$1.53M 0.92% 37
2025
Q3
$22.9M Sell
935,000
-65,000
-7% -$1.58M 2.26% 20
2025
Q2
$23.1M Sell
1,000,000
-650,000
-39% -$17.1M 3.09% 13
2025
Q1
$44.5M Buy
1,650,000
+400,000
+32% +$15.1M 7.92% 4
2024
Q4
$66.9M Buy
1,250,000
+250,000
+25% +$13.2M 7.83% 2
2024
Q3
$45.4M Buy
1,000,000
+250,000
+33% +$10.9M 5.09% 5
2024
Q2
$31.4M Buy
750,000
+600,000
+400% +$28.2M 3.62% 14
2024
Q1
$5.65M Buy
+150,000
New +$3.27M 0.59% 45
2022
Q1
Sell
-185,196
Closed -$3.65M 57
2021
Q4
$3.65M Sell
185,196
-61,926
-25% -$1.3M 0.38% 49
2021
Q3
$4.81M Sell
247,122
-300,000
-55% -$8.63M 0.35% 42
2021
Q2
$13.7M Buy
+547,122
New +$12.2M 1.17% 27

Other funds holding JANX